|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >
Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3 beta and beta-catenin pathway
| Title: | Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3 beta and beta-catenin pathway |
| Authors: | Boku, Shuken Browse this author →KAKEN DB | | Nakagawa, Shin Browse this author →KAKEN DB | | Masuda, Takahiro Browse this author | | Nishikawa, Hiroyuki Browse this author | | Kato, Akiko Browse this author | | Takamura, Naoki Browse this author | | Omiya, Yuki Browse this author | | Kitaichi, Yuji Browse this author | | Inoue, Takeshi Browse this author →KAKEN DB | | Kusumi, Ichiro Browse this author →KAKEN DB |
| Keywords: | Neurogenesis | | Glucocorticoid | | Mood disorder | | Mood stabilizer | | Hippocampus |
| Issue Date: | 15-Jan-2014 |
| Publisher: | Elsevier science bv |
| Journal Title: | European journal of pharmacology |
| Volume: | 723 |
| Start Page: | 425 |
| End Page: | 430 |
| Publisher DOI: | 10.1016/j.ejphar.2013.10.060 |
| PMID: | 24211784 |
| Abstract: | Neurogenesis in the adult dentate gyrus (DC) is decreased in rodent models for mood disorders. Mood stabilizers including lithium (Li) and valproate (VPA) increase it. These increasing effects of Li and VPA on neurogenesis in adult DG are considered to be one of the therapeutic actions of Li and VPA, but their molecular mechanism remains unclear. We have already reported that Li recovers the inhibitory effects of dexamethasone (DEX), an agonist of glucocorticoid receptor, on the proliferation of adult rat DG-derived neural precursor cells (ADP) via GSK-3 beta and beta-catenin pathway. Following it, here we investigated the mechanism underlying the recovery effects of VPA on DEX-induced decrease of ADP proliferation. VPA is an inhibitor of histone deacetylase (HDAC). However, Trichostatin A, a HDAC inhibitor, had no effect on ADP proliferation. In contrast, SB415286, a specific GSK-3 beta inhibitor, recovered DEX-induced decrease of ADP proliferation. In addition, quercetin (Que), a beta-catenin pathway inhibitor, abolished such a recovery effect of VPA. Moreover, nuclear p-catenin and the expression of cyclin D1 were altered by DEX. VPA and Que like the proliferation. Moreover, VPA increased the phosphorylation of Ser(9), which is known as the inhibitory phosphorylation site of GSK-3 beta. These suggest that HDAC is not involved in the recovery effect of VPA on ADP proliferation and that VPA recovers the inhibitory effects of DEX via increasing the phosphorylation of Ser9 on GsK-3 beta and following up-regulation of beta-catenin pathway. Therefore, GSK-3 beta and beta-catenin pathway might play a role in the increasing effects of VPA on neurogenesis on adult DC. (C) 2013 Elsevier B.V. All rights reserved, |
| Type: | article (author version) |
| URI: | http://hdl.handle.net/2115/56639 |
| Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 朴 秀賢
|
